Metropolis Healthcare Sees 13.4% Revenue Growth in Q2 FY25

Metropolis Healthcare reported a strong 13.4% growth in revenue for Q2 FY25, driven by higher demand for its diagnostic services. The company also saw an increase in tests across its network of labs and clinics. Despite challenges in the healthcare sector, Metropolis continues to expand its market share, reinforcing its position as a leading player in the diagnostic services industry.